International Clinical Trial: Efficacy Evaluation of Third-Generation EGFR-TKIs in Advanced T790M-Negative EGFR-Mutant NSCLC Patients Following Progression on First-/Second-Generation EGFR-TKIs Based on a Lung Cancer-Specific Database: A Retrospective Study

Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134774) titled 'Efficacy Evaluation of Third-Generation EGFR-TKIs in Advanced T790M-Negative EGFR-Mutant NSCLC Patients Following Progression on First-/Second-Generation EGFR-TKIs Based on a Lung Cancer-Specific Database: A Retrospective Study' on Oct. 20.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Affiliated Hospital of Guangdong Medical University

Condition: Non-small cell lung cancer

Intervention: Third-generation EGFR-TKIs group:None

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-03

Target Sample Size: Third-generation EGFR-TKIs group:50;Non-third-gener...